Evidence that antioxidants prevent the inhibition of Na+,K+-ATPase activity induced by octanoic acid in rat cerebral cortex in Vitro

Neurochemical Research

Volumn 28, Issue 8, 2003, Pages 1255-1263

  De Assis, Dênis R ^a   Ribeiro, César A J ^a   Rosa, Rafael B ^a   Schuck, Patricia F ^a   Dalcin, Karina B ^a   Vargas, Carmen R ^b   Wannmacher, Clóvis M D ^a   Dutra Filho, Carlos S ^a   Wyse, Angela T S ^a   Briones, Paz ^c   Wajner, Moacir ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Institut de Bioquimica Clinica Barcelona   (Spain)

Author keywords

Antioxidants; Decanoic acid; MCAD deficiency; Na+,K+ ATPase; Octanoic acid; Reye syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ANTIOXIDANT; CREATINE KINASE; DECANOIC ACID; GLUTATHIONE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; OCTANOIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN HOMOGENATE; CONTROLLED STUDY; ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; REYE SYNDROME; SYNAPSE;

ANIMALS; ANTIOXIDANTS; CEREBRAL CORTEX; MALE; NA(+)-K(+)-EXCHANGING ATPASE; OCTANOIC ACIDS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0038385880     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024244915832     Document Type: Article

References (55)

1. Reye, R. D. K., Morgan, G., and Baral, J. 1963. Encephalopathy and fatty degeneration of the viscera: A disease entity in childhood. Lancet 2:749-752.
2. Mamunes, P., DeVries, C. H., Miller, C. O., and David, R. B. 1975. Fatty acid quantitations in Reye's syndrome. Pages 245-254, in Pollack, J. D. (ed.), Reye's syndrome. Grune and Stratton, New York.
3. Trauner, D. A. 1982. Pathologic changes in a rabbit model of Reye's syndrome. Pediatr. Res. 16:950-953.
4. Trauner, D. A. 1981. Intracranial pressure elevations during octanoate infusion in rabbits: An experimental model of Reye's syndrome. Pediatr. Res. 15:1097-1099.
5. Partridge, W. M., Connor, J. D., and Crawford, I. L. 1975. Permeability changes in the blood-brain barrier: Causes and consequences. CRC Crit. Rev. Toxicol. 3:159-199.
6. Sorensen, R. G. and Mahler, H. R. 1982. Localization of endogenous ATPases at the nerve terminal. J. Bioernerg. Biomembr. 14:527-547.
7. Rinaldo, P., Raymond, K., Al-Odaib, A., and Bennett, M. 1998. Clinical and biochemical features of fatty acid oxidation disorders. Curr. Opin. Pediatr. 10: 615-621.
8. Roe, C. R. and Ding, J. 2001. Mitochondrial fatty acid oxidation disorders. Pages 1909-1963, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), The metabolic and molecular bases of inherited disease. (8th ed.) McGraw-Hill, New York.
9. Erecinska, M. and Silver, I. A. 1994. Ions and energy in mammalian brain. Prog. Neurobiol. 43:37-71.
10. Lees, G. J. 1993. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:287-322.
11. +-ATPase activity after brain ischemia. Neurochem. Res. 25:969-973.
12. +-ATPase pump in epilepsy. Ann. Neurol. 16 (Suppl):128-134.
13. +-ATPase inhibition induced by free radicals. Z. Natuforsch. 55c:271-277.
14. Parker, W. D., Haas, R., Stumpf, D. A., and Eguren, L. A. 1983. Effects of octanoate on rat brain and liver mitochondria. Neurology. 33:1374-1377.
15. Walker, C. O., McCandless, D. W., McGarry, J. D., and Schenker, S. 1970. Cerebral energy metabolism in short chain fatty acid induced coma. J. Lab. Clin. Med. 76:569-583.
16. Olson, J. E., Holtzmann, D., Sankar, R., Lawson, C., and Rosenberg, R. 1989. Octanoic acid inhibits astrocyte volume control: Implications for cerebral edema in Reye's syndrome. J. Neurochem. 52:1197-1202.
17. +-ATPase activity following octanoate administration. Pediatr. Res. 14:844-845.
18. McCandless, D. W. 1985. Octanoic acid-induced coma and reticular formation energy metabolism. Brain Res. 335:131-137.
19. Stanley, C. A., Hale, D. E., Coates, P. M., Hall, C. L., Corkey, B. E., Yang, W., Kelley, R. I., Gonzales, E. L., Williamson, J. R., and Baker, L. 1983. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr. Res. 17:877-884.
20. Fischer, J. C., Ruitenbeek, W., Berden, J. J., Trijbels, J. M., Veerkamp, J. H., Stadhouders, A. M., Sengers, R. C., and Janssen, A. J. 1985. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta. 153:23-36.
21. Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., and Munnich, A. 1994. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta. 228:35-51.
22. Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden C. D. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823-827.
23. Birch-Machin, M. A., Briggs, H. L., Saborido, A. A., Bindoff, L. A., and Turnbull, D. M. 1994. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem. Med. Metab. Biol. 51:35-42.
24. Hughes, B. P. 1962. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta. 7:597-604.
25. Jones, D. H. and Matus, A. I. 1974. Isolation of synaptic plasma membrane from brain by combined flotation-sedimenliation density gradient centrifugation. Biochim. Biophys. Acta. 356: 276-287.
26. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem. J. 22:301-301.
27. +-ATPase activity caused by homocisteine. Int. J. Dev. Neurosci. 20:77-81.
28. 2+-stimulated ATPase activity. Anal. Biochem. 157:375-380.
29. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-267.
30. Silva, C. G., Ribeiro, C. A. J., Leipnitz, G., Dutra-Filho, C. S., Wyse, A. T. S., Wannmacher, C. M. D., Sarkis, J, J. F., Jakobs, C., and Wajner, M. 2002. Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro, Biochim. Biophys. Acta. 1586:81-91.
31. Heubi, J. E., Partin, J. C., Partin, J. S., and Schubert, W. K. 1987. Reye's syndrome: Current concepts. Hepatology. 7:155-164.
32. Henneberry, R. L. Novelli, A., Cox, J. A., and Lysko, P. G., 1989. Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons: An hypothesis for cell death in aging and disease. Ann. NY Acad. Sci. 568:225-233.
33. Holtzman, D., Meyers, R., Khait, I., and Jensen, F. 1997. Brain creatine kinase reaction rates and reactant concentrations during seizures in developing rats. Epilepsy Res. 27:7-11.
34. Schapira, A. H. V. 1999. Mitochondrial disorders. Biochim. Biophys. Acta. 1410:99-102.
35. Das, A. M., Fungerhut, R., Wanders, R. J. A., and Ullrich, K. 2000. Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls. Eur. J. Pediatr. 159:243-246.
36. Ventura, F. V., Ruiter, J. P. N., Ijlst, L., Tavares de Almeida, I., and Wanders, R. J. A. 1995. Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acid β-oxidation intermediates on mitochondrial oxidative phosphorylation. J. Inherit. Metab. Dis. 19:161-164.
37. + ATPase leading to inhibition and inactivation. Biochim. Biophys. Acta. 1024:32-40.
38. +-ATPase. Biochim. Biophys. Acta. 815:16-24.
39. +)-activated ATPase. XLIX. Content and role of cholesterol and other neutral lipids in highly purified rabbit kidney enzyme preparation. Biochim. Biophys. Acta. 649:541-549.
40. +)-ATPase: Effects on cation regulation, enzyme conformation, and interactions with ethanol. Arch. Biochem. Biophys. 233:354-361.
41. +-ATPase activity. Mol. Pharmacol. 44:129-141.
42. Abeywardena, M. Y., Allen, T. M., and Charnock, J. S. 1983. Lipid-protein interactions of reconstituted membrane-associated adenosine triphosphatases. Biochim. Biophys. Acta. 729:62-74.
43. +)-stimulated adenosine triphosphatase. J. Biol. Chem. 249:1071-1080.
44. Lee, A. G. 1976. Model for action of local anesthetics. Nature (Lond.) 262:545-548.
45. +-ATPase, and strophanthidin in vitro. Neurochem. Res. 14:845-851.
46. Viani, P., Cervato, G., Fiorilli, A., and Cestaro, B. 1991. Age-related differences in synaptosomal peroxidative damage and membrane properties. J. Neurochem. 56:253-258.
47. Wyss, M., Smeitink, J., Wevers, R. A., and Wallimann, T. 1992. Mitochondrial creatine kinase: A key enzyme of aerobic energy metabolism. Biochim. Biophys. Acta. 1102:119-166.
48. Meister, A. and Anderson, M. E. 1983. Glutathione. Ann. Rev. Biochem. 52:711-760.
49. Burton, G. W., Wronska, U., Stone, L., Foster, D. O., and In-gold, K. U. 1990. Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25:199-210.
50. 2 production following addition of octanoate and oleate in perfused rat liver. Eur. J. Biochem. 141:223-230.
51. Haliwell, B. 1996. Free radicals, protein and DNA: Oxidative damage versus redox regulation. Biochem. Soc. Trans. 24: 1023-1027.
52. Matés, J. M., Pérez-Gómez, C., and Núñez de Castro, I. 1999. Antioxidant enzymes and human diseases. Clin. Biochem. 8: 585-603.
53. Reznick, A. Z. and Pacher, L. 1993. Free radicals and antioxidants in muscular neurological diseases and disorders. Pages 425-437. in Poli, G., Albano, E., and Dianzani, M. U. (eds.), Free radicals: From basic science to medicine, Birkhäuser Verlag, Basel.
54. Duran, M., Bruinvis, L., Ketting, D., de Klerk, J. B. C., and Wadman, S. K. 1988. Cis-4-decenoic acid in plasma: A characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency. Clin. Chem. 34:548-551.
55. Hoffmann, G. F., Meier-Augestein, W., Stockler, S., Surtess, R., Ratirg, D., and Nyhan, W. L. 1993. Physiology and pathology of organic acids in cerebral spinal fluid. J. Inher. Metab. Dis. 16:648-669.